Opinion - Trump is breaking the global order, but maybe that's a good thing.
Long before President Trump reclaimed the White House, the post-World War II global order was fraying. Multilateral institutions were losing relevance, globalization was under siege and great-power politics — including 'might makes right' — had reemerged with a vengeance. From AI arms races to trade wars, the world appeared sliding into disorder.
Trump's second term has turned disruption into a virtual doctrine, including undermining America's longstanding strategic partnerships with countries such as India and South Africa. But, at the global level, his disruption might be precisely the jolt the international system needs.
His critics decry the president as a bull in a geopolitical china shop. They point to Trump's withdrawal from multilateral pacts, his scorched-earth tariff policies and his disdain for NATO allies. Yet amid the upheaval, one question demands serious thought: Could the 'Trump Shock,' which has upended global norms and set in motion the revision of trade and security architecture, actually lay the foundation for a new, more balanced international system?
The so-called 'rules-based international order' has long been a myth. Western powers have invoked a rules-based order as gospel while only selectively adhering to it. From military interventions to extraterritorial sanctions and weaponized finance, the West has bent or broken its own rules when convenient.
Trump has simply been more honest about it. In that honesty, there may be a kind of reform — exposing the myth to force a long-overdue reckoning.
Take trade. Trump's tariff-first strategy has rattled markets, but it also has exposed long-festering trade imbalances. By prioritizing U.S. manufacturing and bilateral deals, his administration has reignited global debates on fair trade, intellectual property theft and overreliance on China. Nations like India and Australia seem poised to benefit from the shifting trade currents Trump has unleashed.
Trump is not so much dismantling globalization as retooling it — from 'free trade at any cost' to 'strategic, reciprocal trade.' The conversation has changed. That's not nothing.
Or consider NATO and Trump's resolve to end European free-riding. His tough talk on NATO — once mocked — is now manifesting in budget shifts across the continent. Allies long dependent on the U.S. for their security are finally raising their defense budgets, realizing that a world without the American umbrella may be approaching. Several NATO members have now edged closer to the 2 percent GDP target for defense.
It is extraordinary that, for decades, Europe chose not to look after its own security and instead rely on America. As Polish Prime Minister Donald Tusk recently pointed out, Europe does not lack economic power or demographic strength — there are '500 million Europeans begging 300 million Americans to defend them against 140 million Russians.'
But today, thanks to Trump, Europe is being nudged toward military self-reliance, thereby strengthening European Union-led defense initiatives. A more militarily self-reliant Europe, cooperating with but not dependent on the U.S., would yield a stronger transatlantic alliance, while allowing Washington to reorient toward the Indo-Pacific region.
Perhaps the clearest example of disruptive reform is Trump's full-throttle decoupling from China. From technology-transfer restrictions to trade war escalation, the U.S. is reversing decades of policy that effectively enabled China's authoritarian rise. By blocking exports of advanced chips to China, the Trump administration is also seeking to thwart China's AI expansion.
The ruling Chinese Communist Party today oversees an 'Orwellian techno-totalitarian surveillance state,' in the words of former Rep. Mike Gallagher (R-Wisc.). China's objective is to first become the regional hegemon in Asia and then to challenge the U.S. for global primacy.
In this light, the Trump administration is seeking to reorient the U.S. military architecture toward the Indo-Pacific to prepare for and win a potential war with China, including deterring a Chinese attack on Taiwan, according to the leaked 'Interim National Defense Strategic Guidance' signed by Secretary of Defense Pete Hegseth. 'China is the Department's sole pacing threat,' the guidance says.
While Trump's rhetoric is fiery, the effect is pragmatic — diversifying supply chains, reinforcing domestic production and galvanizing allies to define their own red lines with Beijing.
Washington's latest push to bind trade deals to 'market economy' status — a jab at China's state-subsidized model — might reshape the rules of 21st-century commerce. To isolate Beijing, the U.S. is seeking to restrict allies' ability to sign trade agreements with any 'non-market economy' like China without full consultations with Washington. This move aims to align allied trade policies with American interests, particularly regarding China's economic practices.
Trump's 'drill, baby, drill' mantra is controversial, but the call for increased energy production has helped soften global prices and offered relief to major energy importing nations like Japan and India. At the same time, it is set to make the U.S. less dependent on unstable energy exporters, giving Washington new leverage in global markets.
There is no denying Trump's style is combative and often norm-defying. But the substance beneath the noise — reshaping of global trade, challenging Chinese hegemony and pushing for alliance rebalancing — deserves a more nuanced evaluation. In a world where the old order is obsolete but the new one has not yet emerged, today's disruptor, Trump, might eventually come to be seen as an accidental reformer.
His presidency is asking hard questions: Should democracies depend on autocracies for critical goods? Why isn't Europe capable of defending itself? Is globalization serving middle-class workers or only multinational companies? These are issues policymakers content with the status quo never dared challenge.
Trump is forcing the conversation. And while sowing some chaos, he is shaking the international order toward a long-overdue realignment. Whether history sees him as a reckless disruptor or a reluctant reformer will depend on whether his shock therapy leads to a sturdier global architecture — or merely a deeper rupture.
Brahma Chellaney is a geostrategist and the author of nine books, including the award-winning 'Water: Asia's New Battleground.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
New Tesla sales in Spain, Portugal fall in May, while other EV sales soar
MADRID (Reuters) -Tesla's new car sales in Spain and Portugal fell in May from the same month in 2024, registration data released by industry groups in both countries showed on Monday, while sales of electric cars from other brands soared. The U.S. EV maker sold 794 cars in Spain and 292 cars in Portugal in May, year-on-year drops of 29% and 68%, respectively. Over the first five months of 2025, sales of Tesla cars in Spain fell 19% from the same period of 2024. Total sales of electrified vehicles, a category that includes both fully electric vehicles and hybrids, were up 72%, ANFAC said. New Tesla sales in the first five months of the year fell 36% in Portugal, the country's automobile industry association ACAP said. Sales of Tesla cars have continued to fall in Europe as CEO Elon Musk's embrace of far-right parties puts off buyers, adding to pressure from a limited range of models and increased competition from European and Chinese brands. Musk left U.S. President Donald Trump's administration last week. He has said he will resume working '24/7' at his companies. In Spain, sales of Chinese automakers BYD, MG and Omoda were up 745%, 87% and 213%, respectively, so far this year, ANFAC's report showed. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Trending tickers: The latest investor updates on Tesla, Palantir, Sanofi, Babcock and Indivior
Shares in Tesla (TSLA) were down nearly 2% in pre-market trading on Monday, amid mixed sales data in Europe for the electric vehicle maker. Data from ANFAC showed that Tesla's new car sales fell by 29% in May, to 794 unit, compared to the same month last year. Meanwhile, data from the Norwegian Road Federation, also released on Monday, showed that the Tesla Model Y was the top seller for new car sales in Norway in May. However, the body also found that Tesla's market share in electric cars had fallen from 21.2% in 2024 to 14% so far this year. Read more: FTSE 100 LIVE: Markets slide as China accuses US of violating trade deal These figures follow data from the European Automobile Manufacturers' Association (ACEA) which showed that sales of Tesla (TSLA) vehicles dropped across Europe by 49% to 7,261 units in April, compared with the same month last year. The EV maker's market share declined to 0.7% from 1.3% in April of 2024. However, shares in Tesla are up nearly 23% over the past month, as CEO Elon Musk has stepped back from the Trump administration, with Musk confirming his his exit from Washington DC last week. Musk has faced backlash over his role heading up DOGE and overseeing cuts to government agencies, with protests having been held at Tesla (TSLA) facilities around the world. Data analytics software firm Palantir (PLTR) was in focus on Monday after shares closed Friday's session up nearly 8%. Shares rose following a New York Times report that the Trump administration had tapped Palantir for a new government contract, to expand the government's tech infrastructure and databases. Stocks: Create your watchlist and portfolio According to the report, Palantir will build a platform that connects sensitive data records across key agencies, such as the Internal Revenue Service (IRS), social security and immigration. A spokesperson for Palantir had not responded to Yahoo Finance UK's request for comment at the time of writing. On the French bourse, shares in Sanofi ( were nearly 1% in the red after the pharmaceuticals firm announced it had agreed to buy US biopharma group Blueprint Medicines (BPMC) for up to $9.5bn (£7.02bn). Blueprint specialises in systemic mastocytosis (SM), a rare immunological disease, and other conditions driven by alterations in the KIT gene. Sanofi's acquisition includes Ayvakit/Ayvakyt, which is the only approved medicine for advanced and indolent systemic mastocytosis. Sanofi said it expects the acquisition to complete in the third quarter of 2025, subject to certain conditions. Read more: Oil prices surge on relief over OPEC+ output hike Paul Hudson, CEO of Sanofi, said: "The proposed acquisition of Blueprint Medicines represents a strategic step forward in our rare and immunology portfolios. It enhances our pipeline and accelerates our transformation into the world's leading immunology company. "This acquisition is fully aligned with our strategic intent to strengthen our existing therapeutic areas, to bring relevant and differentiated medicines to patients and to secure attractive returns to our shareholders." On the London market, defence stocks were in focus, as the UK launched its new strategic review, which is set to call for the armed forces to move to "warfighting readiness to deter the growing threats faced by the UK". That's according to a government announcement on Sunday, which said that the UK is planning to expand its submarine programme in response to the Strategic Defence Review. Prime minister Keir Starmer is set to announce on Monday that the UK will build up to 12 attack submarines in this expansion. Read more: Stocks that are trending today Babcock International Group (BAB.L), which is a key government contractor, was the biggest riser on the FTSE 100 (^FTSE) surging 7%. BAE Systems (BA.L) also rose on Monday morning, advancing nearly 2%. Susannah Streeter, head of money and markets at Hargreaves Lansdown, highlighted that both BAE, as well as Rolls-Royce (RR.L), have "played a key role in designing and building UK nuclear subs". Meanwhile, she said that Babcock shares were up "amid expectations that it will benefit given that it currently maintains the UK's submarine fleet and supports the Ministry of Defence's (MOD) concept of 'continuous at-sea deterrent'." "The government wants the UK's armed forces to be on war-fighting readiness to act as a deterrent, so it seems that higher defence spending is here to stay," she added. In another blow to the UK market, drugmaker Indivior (INDV.L) announced on Monday that it was quitting the London Stock Exchange for the US. Indivior said that it was cancelling its secondary listing on the LSE but would maintain its primary listing on the US Nasdaq (^IXIC). Read more: Stocks to watch this week: Broadcom, Lululemon, British American Tobacco, Dr Martens and Rémy Cointreau Russ Mould, investment director at AJ Bell, said: "Indivior is the latest company to close the door on a London listing. This isn't a shock as Indivior had already given enough hints that its future was entirely Stateside. "It had already switched its main stock listing to the US and effectively said it would monitor the relevance of the secondary listing in the UK. The latter remark was essentially Indivior only propping open the door for an ongoing London presence with its foot. It was just a matter of time before it walked away entirely." Read more: UK house prices rise in May as higher wages, low unemployment boost market Odds of more Bank of England interest rate cuts fall as food inflation rises UK 'bargain' stocks that have outperformed the market long-term
Yahoo
13 minutes ago
- Yahoo
Wall Street futures slip after Trump's steel, aluminum tariff threats
(Reuters) -U.S. stock index futures dipped on Monday after President Donald Trump announced plans to double tariffs on imported steel and aluminum, amplifying concerns about trade- and tariff-related volatility. Trump said on late Friday he planned to increase tariffs on imported steel and aluminum to 50% from 25% starting Wednesday, just hours after he accused China of violating an agreement. The increased levies would deepen Trump's global trade war and douses some enthusiasm stemming from a softening in his trade stance. Last month, a temporary relief on some levies on China and a rollback of steep tariff threats on the European Union, along with strong earnings and improving economic data helped the benchmark S&P 500 log its best monthly performance in 18 months. Shares of U.S. Steel companies rose in premarket trading, with Cleveland-Cliffs jumping 26.2%, Nucor up 14.1% and Steel Dynamics 13.4% higher. "It is really hard to keep up or predict what's going to happen on trade at the moment, and that's before we factor in the full ramifications from the court ruling last Thursday night, and then subsequent brief stay of execution for them on appeal," Jim Reid, global head of macro and thematic research at Deutsche Bank, said in a note. A federal appeals court on Thursday temporarily reinstated most of Trump's 'Liberation Day' tariffs blocked by the Court of International Trade, the day prior. "For now, it seems likely that the tariff uncertainty will linger for a long time ahead even if we're still likely past the peak aggressiveness of U.S. policy," Reid said. At 5:22 a.m. ET, Dow E-minis were down 218 points, or 0.52%, S&P 500 E-minis were down 34 points, or 0.57%. Nasdaq 100 E-minis were down 156.5 points, or 0.73% Most megacap and growth stocks were down, with Tesla leading losses after it reported lower monthly sales in Portugal, Denmark and Sweden. The stock was last down 2%. Focus would be on comments from Fed Chair Jerome Powell later in the day as he presents opening remarks before the Federal Reserve Board International Finance Division's 75th anniversary conference at 1:00 p.m. ET (1700 GMT). Federal Reserve Governor Christopher Waller said on Monday that interest rate cuts remain possible later this year even with the Trump administration's tariffs likely to push up price pressures temporarily. On the data front, a reading of S&P Global U.S. manufacturing PMI is due at 9:45 a.m. ET and an ISM Manufacturing index reading is scheduled for 10:00 a.m. ET. Ahead in the week, investors await a crucial nonfarm-payrolls report due on Friday to ascertain strength in the U.S. economy amid tariff volatility. Among other stocks, Moderna rose 4.6% after the U.S. Food and Drug Administration approved its next-generation COVID-19 vaccine for everyone aged 65 and above. Separately, RBC Capital Markets raised its year-end target for the S&P 500 index to 5,730 from 5,550, citing modestly improved U.S. economic outlook and stronger-than-expected corporate earnings.